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Epstein-Barr virus (EBV), an oncogenic herpesvirus asso-
ciated with Burkitt’s lymphoma and other AIDS-related
B cell malignancies, transforms primary human B cells
into lymphoblastoid cell lines (LCLs) ex vivo.A sL C L s
express viral gene products similar to those found in
EBV-mediated cancers, LCLs provide a practical model
for tumorigenesis. Previous unpublished findings from
our lab indicate that LCLs constitutively express the
adhesion molecule CD226 (DNAM-1), found on virtually
all peripheral blood NK cells, T cells, and monocytes, but
only a small subset (~3%) of B cells. Although CD226 is
known to mediate T-cell differentiation and cytotoxicity,
NK cell cytotoxicity, NKT cell apoptosis, and monocyte
extravasion, CD226 function in B cells remains relatively
unstudied. Biochemically, CD226 functions to support
the interaction between the intracellular adhesion mole-
cules LFA-1 and ICAM-1. Here, we demonstrate that
EBV specifically induces CD226 expression in primary
human B cells and EBV-negative B lymphoblasts during
viral-mediated proliferation and outgrowth. EBV infec-
tion of primary B cells increased CD226 surface expres-
sion 5-fold during early proliferation and approximately
30-fold upon transformation into LCLs. EBV-converted
Burkitt’s lymphoma cells constitutively express CD226,
while EBV-negative B cell lymphomas do not. Addition-
ally, we demonstrate that LMP-1, an EBV latency III
membrane oncoprotein, induces CD226 expression in
EBV-negative Burkitt’s lymphoma cells. Finally, we
demonstrate that the NFB pathway regulates CD226
expression. Indeed, B cell lymphomas with high NFB
activity (activated B cell-like diffuse large B-cell lympho-
mas) express CD226 at higher levels than B cell lympho-
mas with low NFB activity (germinal center B cell-like
diffuse large B cell lymphomas). As CD226 supports the
interaction between LFA-1 and ICAM-1, which is critical
to maintain the constitutive aggregation of EBV-trans-
formed B cells, we propose that EBV-mediated induction
of CD226 drives cell-cell contact ensuring B cell survival.
These data suggest that CD226, a newly identified EBV-
induced cell adhesion molecule, may play a key role in
the pathogenesis of AIDS-associated and other B cell
lymphomas.
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